...
首页> 外文期刊>Sarcoma >Incidence and Severity of Lymphoedema following Limb Salvage of Extremity Soft Tissue Sarcoma
【24h】

Incidence and Severity of Lymphoedema following Limb Salvage of Extremity Soft Tissue Sarcoma

机译:肢体软组织肉瘤抢救后淋巴水肿的发生率和严重程度

获取原文

摘要

Background and Purpose. Lymphoedema is a serious complication following limb salvage for extremity soft tissue sarcomas (STSs) for which little is known. We aimed to evaluate its incidence, its, severity and its associated risk factors.Material and Method. Patient and tumor characteristics, treatment modalities and complications and functional outcomes (MSTS 1987, TESS), and lymphoedema severity (Stern) were all collected from prospective databases. Charts were retrospectively abstracted for BMI and comorbidities.Results. There were 289 patients (158 males). Mean age was 53 (16–88). Followup ranged between 12 and 60 months with an average of 35 and a median of 36 months. Mean BMI was 27.4 (15.8–52.1). 72% had lower extremity tumors and 38% upper extremity. Mean tumor size was 8.1 cm (1.0–35.6 cm). 27% had no adjuvant radiation, 62% had 50 Gy, and 11% received 66 Gy. The incidence of lymphoedema was 28.8% (206 none, 58 mild, 22 moderate, 3 severe, and 0 very severe). Mean MSTS score was 32 (11–35) and TESS was 89.4 (32.4–100). Radiation dose was significantly correlated with tumorsize>5 cm (P=0.0001) and TESS score (P=0.001), but not MSTS score (P=0.090). Only tumorsize>5 cm and depth were found to be independent predictors of significant lymphoedema.Conclusion. Nine percent of STS patients in our cohort developed significant (grade≥2) lymphoedema. Tumorsize>5 cm and deep tumors were associated with an increased occurrence of lymphoedema but not radiation dosage.
机译:背景和目的。肢端软组织肉瘤(STS)挽救肢体后,淋巴水肿是一种严重的并发症,对此鲜为人知。我们旨在评估其发生率,严重性及其相关的危险因素。材料与方法。患者和肿瘤的特征,治疗方式,并发症和功能结局(MSTS 1987,TESS)以及淋巴水肿严重程度(Stern)均从前瞻性数据库中收集。对BMI和合并症的图表进行回顾性提取。有289名患者(158名男性)。平均年龄为53岁(16-88岁)。随访时间为12至60个月,平均35个月,中位数36个月。平均BMI为27.4(15.8-52.1)。下肢肿瘤占72%,上肢肿瘤占38%。平均肿瘤大小为8.1 cm(1.0-35.6 cm)。 27%的患者没有辅助放射,62%的患者接受了50 Gy,11%的患者接受了66 Gy。淋巴水肿的发生率为28.8%(206例无,轻度58例,中度22例,严重3例,非常严重0例)。平均MSTS评分为32(11–35),TESS为89.4(32.4–100)。放射剂量与肿瘤大小> 5 cm(P = 0.0001)和TESS评分(P = 0.001)显着相关,而与MSTS评分无关(P = 0.090)。仅发现肿瘤大小> 5 cm和深度是显着淋巴水肿的独立预测因子。在我们队列中,有9%的STS患者出现了明显的(≥2级)淋巴水肿。肿瘤大小> 5 cm和深部肿瘤与淋巴水肿的发生率增加有关,而与放射剂量无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号